Answers are grounded in this paper and cite their sources.
We performed prospective screening of stool for multidrug-resistant organisms from 608 US international travelers and identified an acquisition rate of 38% following travel. Carriage rates remained significantly elevated for at least 6 months post-travel. Travel-related diarrhea was a risk factor for acquisition, as well as for long-term carriage upon return.
No takes yet. Share an insight, caveat, or question.
Worby et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: